Instructions for Amlodipine Aspartate Tablets
Release time:
2020-07-31
Approval Date: October 23, 2006
First Amendment Date: June 20, 2010
Second Amendment Date: May 05, 2015
Amlodipine Aspartate Tablets Instruction
Aspartic acid Amlodipine Tablets
Please read the instruction carefully and use
[Drug Name]
generic name under the guidance of a doctor: amlodipine aspartate tablets
trade name: liside
English name: Aspartic acid Amlodipine Tablets
Chinese pinyin: Men dong an suan an lu di ping plan-
[ingredients] the main ingredient of this product is L-amlodipine aspartate
chemical name: 2-1 [2-aminoethoxy] methyl] -4-1 (2-chlorophenyl) -1,4-dihydrogen -6-methyl pyridine -3,5-3-ethyl -5-methyl ester L-a-aspartic acid salt.
Chemical Structural Formula:
Molecular Formula: C20H25CIN205 C4H7N04
Molecular Weight: 541.99
[Character] This product is white or white-like sheet
[Indications] It can be used alone or in combination with other antihypertensive drugs to treat hypertension
[Specification] 5mg (based on amlodipine)
[Usage and Dosage] Usually the initial dose is 5mg (one sheet) once a day, but the elderly, frail, liver damage patients and patients with other antihypertensive drugs, the initial dose can be 2.5mg (half a tablet), once a day. Dosage adjustment should be based on the clinical response of the individual patient, the maximum dose can be increased to 10mg (two tablets), once a day. This product is combined with thiazide diuretics, beta blockers and angiotensin converting enzyme inhibitors without dose adjustment.
[Adverse Reactions] The more common adverse reactions are headache, edema, fatigue, insomnia, nausea, abdominal pain, flushing, palpitations and dizziness. Less common adverse reactions are angina, hypotension, bradycardia, orthostatic hypotension, pruritus, rash, dyspnea, weakness, muscle cramps, and dyspepsia. This product is similar to other calcium antagonists, there are few reports of adverse reactions of myocardial infarction and chest pain, and these adverse reactions can not be clearly distinguished from the patient's own underlying disease; no abnormal laboratory parameters related to this product have been found.
[Contraindications] Patients allergic to dihydropyridine calcium antagonists are contraindicated.
[Precautions]
L. Patients with impaired liver function: As with all other calcium blockers, the half-life of this product is prolonged when liver function is impaired, but the corresponding recommended dose has not yet been determined. Therefore, this product should be used with great care in this case.
2. Patients with renal failure: This product is widely metabolized into inactive metabolites, and only 10% of the drugs are excreted in the original form through urine. Therefore, the change of blood drug concentration is not related to the degree of renal damage. Patients with renal damage can use normal doses. This product is not dialysis.
3. This product, such as other calcium ion blockers, can rarely have gingival hyperplasia, which mostly occurs during 1-9 months of treatment, but symptoms and hyperplasia can be improved l-21 weeks after drug withdrawal.
4. There is no need to stop the drug before surgery, but the anesthesiologist must know to use this drug for treatment.
. The following conditions are prohibited:
① Severe hypotension:
② Aortic stenosis.
[Use for pregnant and lactating women] The safety of this product for pregnant and lactating women has not been established. In animal experiments, rats were given 10 mg/kg of this product. In addition to delayed delivery and prolonged labor, intrauterine death increased 5 times and the number of littermates decreased by 50%. Therefore, this product can only be used when there is no other safer alternative drug and the disease itself is more dangerous to mother and child. There are no reports on whether this product is discharged into milk.
[Children's medication] There is no information on this product for children.
[Elderly Medication] The peak time of blood drug concentration of this product is similar in elderly and young patients. The area under the curve (AUC) of elderly patients is increased, the elimination half-life is prolonged, and the clearance rate is decreased. It has been reported that older patients were as well tolerated as younger patients when receiving similar doses of amlodipine. Therefore, the elderly patients can use the normal dose, but it is advisable to start with a smaller dose, and then gradually increase the appropriate.
[Drug Interactions]
(1) Narcotics: Inhalation of hydrocarbon drugs with this product can cause hypotension.
(2) non-steroidal anti-inflammatory drugs, especially indomethacin: with this product can weaken the hypotensive effect, may be related to the inhibition of prostaglandin synthesis and (or) cause water, sodium retention.
(3) beta blockers: well tolerated with this product, but can cause excessive hypotension, rare cases can increase the possibility of congestive heart failure.
(4) Estrogen: Use with this product can increase fluid retention and increase blood pressure.
(5) Sulfopyrone (sulfinpyrazone): combined with this product can increase the protein binding rate of amlodipine and change the blood drug concentration.
(6) Lithium preparations: When used with this product, it can cause neurotoxicity, such as nausea, vomiting, diarrhea, ataxia, tremor and (or) numbness, and should be used with caution.
(7) Sympathomimetic amines may attenuate the antihypertensive effect of this product.
[Drug Overdose] Existing data suggest that severe overdose can lead to excessive dilatation of peripheral blood vessels, followed by significant and lasting systemic hypotension, bradycardia, rare II or III degree atrioventricular block, and cardiac arrest in a few patients. The former should be given intravenous dopamine, norepinephrine treatment. The latter should be given atropine, isopropyl kidney, calcium chloride treatment, if there are indications should be placed pacemaker.
[Pharmacological Toxicology]
Pharmacological Effects
This product is a calcium ion influx blocker (I. e. calcium channel blocker or calcium ion antagonist), which can selectively inhibit calcium ion from flowing into vascular smooth muscle and myocardial cells across the membrane, especially for vascular smooth muscle. This product directly dilates vascular smooth muscle, dilates peripheral arterioles, reduces peripheral resistance (afterload), and significantly dilates coronary arteries. This product has a negative inotropic effect in vivo, but has no effect on the sinoatrial node and atrioventricular node.
Toxicological Study
Acute Toxicity in Mice: The LD 50 of L-aspartate amlodipine bulk drug administered by gavage is 80.2 mg/kg(95% confidence limit is 71.3-90.2 mg/kg); The LD 50 for intraperitoneal injection is 62.1 mg/kg(95% confidence limit is 55.0-70.1 mg/kg).
Genotoxicity: Mutagenicity test results indicate no drug-related gene or chromosome level mutagenicity.
Reproductive toxicity: General reproductive toxicity test, oral administration of amlodipine 10 mg/kg/day (based on body surface area, about 8 times the maximum recommended human dose of lOmg) to rats has no damage to fertility. Oral administration of 10 mg/kg of amlodipine (about 8 times and 23 times the maximum recommended human dose of 10mg in terms of body surface area, respectively) to pregnant rats and rabbits during organogenesis had no teratogenic effect on embryos. However, oral administration of amlodipine 10 mg/kg 14 days before mating and pregnancy in rats significantly reduced the number of littermates (about 50%), increased intrauterine mortality (about 5 times), and prolonged pregnancy and labor. Adequate and well-controlled trials have not been conducted in pregnant women, so pregnant women should only take this product during pregnancy when their potential benefits are large and potentially dangerous to the fetus.
It is not clear whether this product is excreted in human milk. In view of the lack of information in this regard, it is recommended to stop using it during lactation.
Carcinogenicity: Amlodipine is carcinogenic in rats and mice for two years. Mixed food doses of 0.5,1.25, and 2.5 mg/kg/day are non-carcinogenic. The highest dose (calculated by body surface area, the mouse dose is equivalent to the maximum recommended clinical dose of 10mg, while the rat dose is twice) is close to the maximum tolerance of mice.
[Pharmacokinetics] It is reported in the literature that this product is well absorbed orally and is not affected by food intake. The plasma protein binding rate is about 97.5, the blood drug concentration reaches the peak value 6-12 hours after single administration, the absolute bioavailability is about 64-80%, the apparent distribution volume is about 21L/kg, the final elimination half-life is about 35-50 hours, once a day, after 7-8 days of continuous administration, blood drug concentration reached steady state. This product is widely metabolized by the liver into inactive metabolites, 10% of which are excreted as original drugs and 60% as metabolites through urine.
【Storage】 Shaded, sealed and stored in a dry place..
【Packing】 Aluminum-plastic plate packaging, each small carton containing seven or fourteen pieces.
[Validity] 24 months.
[Implementation Standard] WS-(X-101)-2005Z
[Approval Document No.] Guoyao Zhun Zi H20020487
[Production Enterprise]
Enterprise Name: Zhejiang Jianfeng Pharmaceutical Co., Ltd.
Address: No. 58 Gaofan Section, Baitang Downline, Wucheng District, Jinhua City, Zhejiang Province
Tel: 0579-82661998 (Consultation) 0579-82131973 (Sales)
Fax
:
More information
Passion to sing praises to the party
On June 26, the Jinhua United Front "Tongxin · Ode" chorus competition to celebrate the 100 anniversary of the founding of the Communist Party of China was held at the Jinhua Cultural Center Theater. The Jinhua City Federation of Industry and Commerce team, composed mainly of peak employees, won the bronze award for the song "Under the Brilliant Sunshine" in the competition.
2021
07-01
On the morning of July 1, a grand celebration of the 100 anniversary of the founding of the Communist Party of China was held in Tiananmen Square in Beijing. Xi Jinping, General Secretary of the CPC Central Committee, President of the State, and Chairman of the National Military Commission, delivered an important speech. At 8: 00 a.m. in the conference room of the peak building, members of the party Committee of the group company, members of the management team, functional departments and employees of subordinate enterprises working in the peak building were present on time to watch the live broadcast of the celebration. The subordinate enterprises of the company also organized party members and cadres to watch the live broadcast and celebrate the party's centtieth birthday in the form of raising the national flag and reviewing the oath of joining the party.
2021
07-01
Group Party Committee Visits Old Party Members
As the 100 anniversary of the founding of the Communist Party of China approaches, on June 9, the group party committee visited and expressed condolences to old party members and party members in difficulties, and sent them holiday blessings and greetings. The picture shows Qin Xuping, member of the group's party committee and director of the party and mass work department, on behalf of the group's party committee, expressing condolences to Xu Zeng, the first batch of employees and veteran party members of Jinhua cement factory, the predecessor of the peak, when it started its business in 1958.
2021
06-22
"I volunteer to join the Communist Party of China, support the party's program, abide by the party's constitution, fulfill the obligations of party members ......" On the morning of June 6, at the site of the Gutian Conference in Shanghang County, Fujian Province, more than 30 pinnacle party members solemnly raised their right fists facing the party flag to revisit the oath of joining the party. Visiting and studying the red education base and reviewing the oath of joining the party are important contents of the study and education of party history. Yu Jianhong, Qin Xuping and Chen Tianci, members of the group's party committee, party members of various branches of the group's headquarters, and secretaries of grass-roots party organizations under the group's party committee, totaling more than 30 people, visited and studied at the Gutian conference site. Party members visited the Gutian Conference site, the Chairman's Memorial Garden, the Gutian Conference Memorial Hall and other red attractions, and presented flower baskets to the statue of Comrade Mao Zedong. The Gutian Conference was the ninth party congress held by the Fourth Army of the Chinese Workers' and Peasants' Red Army in Gutian Village, Shanghang County, Fujian Province from December 28 to 29, 1929. This meeting summed up the experiences and lessons of army building since the founding of the fourth Red Army, established the principle of the party's absolute leadership over the Red Army, combined Marxism-Leninism with the concrete practice of China's revolutionary struggle, and solved the fundamental problem of how to maintain the party's proletarian vanguard nature and build a new type of people's army by strengthening the party's ideological work. It is of great significance in the history of the development of the Communist Party of China and the Workers' and the Red Army. During the visit and study, the party members visited the display of revolutionary cultural relics, listened to the explanation, got a close understanding of the revolutionary process of building the party and army under difficult conditions, and accepted the spiritual baptism of ideals and beliefs.
2021
06-11
Spike can independently determine the level of professional skills!
A few days ago, after the examination and approval of Jinhua Human Resources and Social Security Bureau, and reported to the Provincial Department of Human Resources and Social Security for examination and record, Zhejiang Jianfeng Group Co., Ltd. was approved to independently identify the level of vocational skills. High-skilled talents are an important part of the enterprise talent team, and they are the backbone to promote technological innovation and promote the transformation of modern scientific and technological achievements into real productivity. Therefore, Jianfeng Group attaches great importance to strengthening the construction of senior technicians, technicians, senior technicians and other talent teams and the training of skilled talents. In recent years, the entire group company has carried out various forms of skills training based on the improvement of employees' job skills. Last year alone, more than 8000 person-times of job skills training were held, which improved employees' professional skills and business capabilities. Under the background of digital and intelligent production, effectively stimulating front-line employees to learn skills and drill business, and cultivating and building a highly skilled workforce is one of the important means to promote the high-quality development of enterprises. At the beginning of the year, the human resources department of the group began to prepare to rely on the national vocational skill identification standards, and formulated the national vocational skill level independent identification scheme of Jianfeng group for the group's two main businesses of cement and pharmaceutical industry. after the comprehensive evaluation of the municipal human resources and social security bureau and Jinhua vocational skill management service center, the group company was agreed to become the independent identification unit of vocational skill level. The success of the application for the independent identification of the vocational skill level of the group company marks the company's skilled talent evaluation work, which has realized the transformation from government-led to the autonomy of employers, combining evaluation with training, use and incentives, and expanding the growth channel of skilled talents. It has laid a good foundation for promoting skill upgrading actions and building knowledge-based, skilled and innovative industrial workers. The positions independently identified by the group company's professional skill level are mainly in the two main businesses of cement and pharmaceutical industry, specifically cement production workers (including cement central controller, cement quality inspector, cement clinker calciner, cement manufacturer, cement production inspection worker, etc.) and pharmaceutical preparation workers. The group is about to carry out the independent identification of vocational skill levels for these two categories of work.
2021
05-21
On April 27, Qiandongnan Prefecture of Guizhou Province held a conference to celebrate the "May 1st" International Labor Day. Huangping Jianfeng Cement Company was awarded the May 1st Labor Certificate of Qiandongnan Prefecture at the conference. Tang Yueqiang, Secretary of the Party Leadership Group and Director of the Standing Committee of the People's Congress of Qiandongnan Prefecture, hoped in his speech that the broad masses of employees in the prefecture will keep in mind the ardent entrustment of General Secretary Xi Jinping, closely focus on the overall situation of the prefecture, consciously shoulder the glorious mission, and vigorously promote the spirit of model workers and labor. The spirit of craftsmanship and the spirit of Guizhou in the new era are striving to be knowledge, skilled and innovative workers in the new era, make new contributions and create new glories in the new journey of building socialist modernization. The conference named and commended the collectives and individuals who won the Qiandongnan May 1st Labor Award, the Worker Pioneer, and the Qiandongnan Craftsman Honors. 40 units including Huang Ping Jianfeng won the Qiandongnan Prefecture May 1st Labor Award. In addition, on the afternoon of May 7, Huangping County, Guizhou Province held the 2021 model worker and advanced worker commendation meeting to commend 11 model workers and 19 advanced workers. Qian Jiang, deputy secretary of the Jianfeng Party branch of Huangping and chairman of the trade union, was awarded the honor of "model worker" in Huangping County. Yang Zhi, deputy secretary of the Huangping County CPC Committee and county magistrate, called on the whole county to vigorously carry forward the spirit of model workers, labor spirit, and craftsmanship, so as to make it a common practice to advocate model workers, learn from model workers, and strive to be model workers, and further gather powerful forces to speed up the high-quality development of Huangping. As a model worker representative, Qian Jiang made an experience exchange speech at the conference.
2021
05-21
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page